DFTX

Definium Therapeutics, Inc.

DFTX·24477V105·US·Common Stock·Healthcare - Biotechnology-13D/G

DFTX (Definium Therapeutics, Inc.) is held by 160 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($528.4M), Avoro Capital Advisors LLC ($338.2M), DRIEHAUS CAPITAL MANAGEMENT LLC ($322M). Net institutional sentiment: Bullish.

160
Holders
(16 Elite)
$3.9B
Total Value
74% (166)
Consensus
123 buying - 43 selling
13F: Insider & Congress: Updated regularly
DFTX

Smart Money Verdict

View all
Loading verdict
Held by 160 funds
16 elite

Who's Trading

Source dates: Price Aug 27, 2026 · Insiders Mar 26, 2026 · Activists Aug 14, 2026 · Congress none

ActivistDRIEHAUS CAPITAL MANAGEMENT LLCDRIEHAUS CAPITAL MANAGEMENT LLC5.4%Aug 14, 2026
ActivistCOCommodore Capital LP1.8%Aug 14, 2026
ActivistDTDeep Track Capital, LP3.0%May 15, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
11.2M(+32.5%)$528.4M0.0%+75.91%
40
Increased
7.2M(+43.8%)$338.2M3.0%+64.38%
78
Increased
6.8M(+15.8%)$322M1.9%+148.72%
56
New
5.4M$252.5M0.0%-6.95%
43
Increased
4.8M(+162.7%)$223.6M0.0%+22.04%
49
Increased
3.6M(+46.1%)$171.5M0.0%+62.44%
41
Increased
3.1M(+24.0%)$144.2M0.0%+87.27%
37
New
3M$139.4M0.0%-6.95%
42
Increased
2.9M(+126.1%)$138.8M0.0%+28.52%
49
Increased
1.8M(+7.5%)$84.7M0.0%+121.80%
32
Increased
1.7M(+26.6%)$79.4M0.0%+83.42%
37
Increased
1.6M(+88.9%)$77.5M0.0%+38.94%
47
New
1.5M$70.6M0.6%-6.95%
58
Increased
1.5M(+35.5%)$69.9M0.0%+72.46%
38
Increased
1.3M(+8.2%)$61.1M0.0%+181.93%
32
Increased
1.2M(+46.3%)$55M0.0%+62.21%
40
Increased
1.1M(+18.8%)$54M0.0%+95.97%
35
Increased
1.1M(+58.3%)$52M0.0%+53.57%
42
Increased
1.1M(+34.0%)$51M0.0%+74.14%
38
Increased
1M(+33.3%)$47.2M0.1%+74.90%
45

Showing 1-20 of 168

1 / 9
DFTXDFTXDefinium Therapeutics, Inc.

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used